Foghorn Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
11 Mar 24 | SellUS$72,134 | Fanny Cavalie | Individual | 11,000 | US$6.56 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 4,000,000 | 7.2% |
Individual Insiders | 4,534,949 | 8.16% |
General Public | 5,118,119 | 9.21% |
Hedge Funds | 8,329,886 | 15% |
VC/PE Firms | 12,674,120 | 22.8% |
Institutions | 20,936,057 | 37.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
12,674,120 | US$99.6m | 0% | 27.44% | |||
6,333,984 | US$49.8m | -0.77% | no data | |||
5,302,000 | US$41.7m | 0% | 1.28% | |||
4,000,000 | US$31.4m | 0% | no data | |||
3,624,379 | US$28.5m | 0% | no data | |||
3,027,886 | US$23.8m | 20.2% | 0.42% | |||
2,297,319 | US$18.1m | -1.76% | 0.01% | |||
2,139,639 | US$16.8m | 0% | no data | |||
1,731,979 | US$13.6m | 63.5% | no data | |||
1,573,761 | US$12.4m | 0% | 1.4% | |||
1,546,069 | US$12.2m | 0% | no data | |||
720,720 | US$5.7m | 0% | 0.28% | |||
677,386 | US$5.3m | 27.5% | no data | |||
511,704 | US$4.0m | 0% | no data | |||
505,945 | US$4.0m | 4.9% | no data | |||
500,901 | US$3.9m | 0% | 0.26% | |||
399,702 | US$3.1m | -1.71% | 0.01% | |||
320,930 | US$2.5m | 0% | 2.33% | |||
250,798 | US$2.0m | 31.3% | no data | |||
151,957 | US$1.2m | -11.6% | no data | |||
129,331 | US$1.0m | -29.8% | no data | |||
121,672 | US$956.3k | 0% | 0.46% | |||
108,068 | US$849.4k | 66.6% | no data | |||
107,329 | US$843.6k | 0% | 0.1% | |||
86,992 | US$683.8k | 0% | no data |